Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 22, 2026
The phase III DUO trial of PI3K inhibitor duvelisib versus ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival.
Journal: Haematologica
Published: January 26, 2024
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
Journal: Frontiers in oncology
Published: December 07, 2023
Association of Selinexor Dose Reductions With Clinical Outcomes in the BOSTON Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: August 02, 2023
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 04, 2023
Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction - A post hoc analysis of the cel-02 phase IIa study.
Journal: American heart journal
Published: December 19, 2022
Serum aldosterone and urine electrolytes dynamics in response to DASH diet intervention - An inpatient mechanistic study.
Journal: Journal of clinical and translational science
Published: December 13, 2021
Effect of Normalizing eGFR to Standard Body Surface Area on Rates of Obesity-Related Hyperfiltration among Diverse Female Adolescents.
Journal: American journal of nephrology
Published: December 08, 2021
Obesity Related Glomerulopathy in Adolescent Women: The Effect of Body Surface Area.
Journal: Kidney360
Published: August 13, 2021
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
Journal: British journal of cancer
Published: July 14, 2021
CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.
Journal: Journal of clinical and translational science
Published: June 30, 2021
Last Updated: 09/26/2026